Abstract

Case Report

Leiomyosarcoma in pregnancy: Incidental finding during routine caesarean section

Toon Wen Tang* and Phoon Wai Leng Jessie

Published: 16 August, 2021 | Volume 4 - Issue 3 | Pages: 092-095

Uterine leiomyosarcoma (LMS) is uncommon tumour arising from the female reproductive tract. Incidence of LMS in pregnancy is extremely rare, with only 10 cases reported thus far in medical literature.
We present a case of myomectomy performed during elective caesarean section for breech presentation, due to its easy accessibility and well contracted uterus. Subsequent histology revealed LMS on final specimen. Patient subsequently underwent total abdominal hysterectomy, bilateral salpingo-oophorectomy. No chemotherapy was given as she opted for close clinical- radiological monitoring instead. 
This case report highlights the importance of discussion with patients regarding the risk of occult malignancy in a fibroid uterus. Appropriate management of uterine leiomyosarcoma in pregnancy remains unclear. Consideration of removing an enlarging leiomyoma during caesarean section might be ideal in view of its malignant potential, just like in this case; however, location of the tumour and risk of bleeding needs to be weighed. Ultimately, management of such cases needs proper discussion between obstetrician and the patient.

Read Full Article HTML DOI: 10.29328/journal.cjog.1001094 Cite this Article Read Full Article PDF

Keywords:

Leiomyosarcoma; Pregnancy; Caesarean section

References

  1. Gallup DG, Cordray DR. Leiomyosarcoma of the uterus: case reports and a review. Obstet Gynecol Surv. 1979; 34: 300-312. PubMed: https://pubmed.ncbi.nlm.nih.gov/471365/
  2. Park JY, Park SK, Kim DY, Kim JH, Kim YM, et al. The impact of tumor morcellation during surgery on the prognosis of patients with apparently early uterine leiomyosarcoma. Gynecol Oncol. 2011; 122: 255–259. PubMed: https://pubmed.ncbi.nlm.nih.gov/21565389/
  3. Lissoni A, Cormio G, Bonazzi C, Perego P, Lomonico S, et al. Fertility-sparing surgery in uterine leiomyosarcoma. Gynecologic Oncol. 1988; 70: 348–350. PubMed: https://pubmed.ncbi.nlm.nih.gov/9790786/
  4. Kyodo Y, Inatomi K, Abe T. Sarcoma associated with pregnancy. Am J Obstet Gynaecol. 1989; 161: 94–96. PubMed: https://pubmed.ncbi.nlm.nih.gov/2750827/
  5. Matsuo K, Eno ML, Im DD, Rosenshein NB. Pregnancy and genital sarcoma: a systematic review of the literature. Am J Perinatol. 2009; 26: 507–518. PubMed: https://pubmed.ncbi.nlm.nih.gov/19288396/
  6. Flake GP, Andersen J, Dixon D. Etiology and pathogenesis of uterine leiomyomas: a review. Environ Health Perspect. 2003; 111: 1037-1054. PubMed: https://pubmed.ncbi.nlm.nih.gov/12826476/
  7. Tinelli A, Malvasi A, Mynbaev OA, Barbera A, Perrone E, et al. The surgical outcome of intracapsular cesarean myomectomy. A match control study. JMatern Fetal Neonatal Med. 2013; 27: 66-71. PubMed: https://pubmed.ncbi.nlm.nih.gov/23662726/
  8. Ramesh Kumar R, Patil M, Shruthi SA. The utility of caesarean myomectomy as a safe procedure: A retrospective analysis of 21 cases with review of literature. JClin Diagn Res. 2014; 8: OC05-8. PubMed: https://pubmed.ncbi.nlm.nih.gov/25386485/
  9. Kanthi, JM, Sumathy S, Sreedhar S, Rajammal B, Usha MG, et al. Comparative Study of Cesarean Myomectomy with Abdominal Myomectomy in Terms of Blood Loss in Single Fibroid. J Obstet Gynaecol India. 2016; 66: 287-291. PubMed: https://pubmed.ncbi.nlm.nih.gov/27382224/
  10. Li H, Du J, Jin LY, Shi Z, Liu MY. Myomectomy during cesarean section. Acta Obstetricia et Gynecologica Scandinavica. 2009; 88: 183-186.
  11. Machado LS, Gowri V, Al-Riyami N, Al-Kharusi L. Caesarean myomectomy. Feasibility and safety. Sultan Qaboos Univ Med J. 2012; 12: 190-196. PubMed: https://pubmed.ncbi.nlm.nih.gov/22548138/
  12. Song DR, Zhang W, Chames MC, Guo J. Review article. Myomectomy during cesarean delivery. Int JGynaecol Obstet. 2013; 121: 208-213. PubMed: https://pubmed.ncbi.nlm.nih.gov/23507551/
  13. Bužinskienė D, Mikėnas S, Drąsutienė G. Uterine sarcoma: a clinical case and a literature review. Acta MedLitu. 2018; 25: 206-218. PubMed: https://pubmed.ncbi.nlm.nih.gov/31308826/
  14. Harry VN, Narayansingh GV, Parkin DE. Uterine leiomyosarcomas: a review of the diagnostic and therapeutic pitfalls. Obstetrician Gynaecologist. 2007; 9: 88-94.
  15. Leitao MM, Sonoda Y, Brennan MF, Barakat RR, Chi DS. Incidence of lymph node and ovarian metastases in leiomyosarcoma of the uterus. Gynecol Oncol. 2003; 91: 209–212. PubMed: https://pubmed.ncbi.nlm.nih.gov/14529683/
  16. Goff BA, Rice LW, Fleischhacker DN, Muntz HG, Falkenberry SS, et al. Uterine leiomyosarcoma and endometrial stromal sarcoma: lymph node metastases and sites of recurrence. Gynecol Oncol. 1993; 50: 105–109.
  17. Giuntoli RL, Metzinger DS, DiMarco CS, Cha SS, Sloan JA, et al. Retrospective review of 208 patients with leiomyosarcoma of the uterus: prognostic indicators, surgical management, and adjuvant therapy. Gynecol Oncol. 2003; 89: 460-469. PubMed: https://pubmed.ncbi.nlm.nih.gov/12798712/
  18. Hensley ML, Ishill N, Soslow R, Larkin J, Abu-Rustum N, et al. Adjuvant gemcitabine plus docetaxel for completely resected stages I–IV high grade uterine leiomyosarcoma: results of a prospective study. Gynecol Oncol. 2009; 112: 563-567. PubMed: https://pubmed.ncbi.nlm.nih.gov/19135708/
  19. Hensley ML, Wathen JK, Maki RG, Araujo DM, Sutton G, et al. Adjuvant therapy for high-grade, uterus-limited leiomyosarcoma: results of a phase 2 trial (SARC 005). 2013; 119: 1555–1561. PubMed: https://pubmed.ncbi.nlm.nih.gov/23335221/
  20. Omura GA, Blessing JA, Major F, Lifshitz S, Ehrlich CE, et al. A randomized clinical trial of adjuvant adriamycin in uterine sarcomas: a Gynecol Oncol Group Study. J Clin Oncol. 1985; 3: 1240-1245. PubMed: https://pubmed.ncbi.nlm.nih.gov/3897471/

Figures:

Figure 1

Figure 1

Similar Articles

Recently Viewed

Read More

Most Viewed

Read More